Comparative Stroke, Bleeding, and Mortality

ARTICLE IN PRESS Supplementary Figure 3 Hazard ratios (95% confidence intervals) for thromboembolic stroke, intracranial hemorrhage, major extracranial bleeding, and all-cause mortality from a post hoc analysis including all eligible warfarin, dabigatran, rivaroxaban, and apixaban patients in an unweighted multivariable Cox proportional hazards regression model. (A) Nonvitamin K antago- nist oral anticoagulant (NOAC) vs warfarin. (B) NOAC vs NOAC. 9.e11 The American Journal of Medicine, Vol 000, No 000, && 2019